Antigen presenting cells, both dendritic cells and monocytes, will be evaluated in two diseases of cell mediated immunity: AIDS and tuberculosis. Immunological studies of HIV-1 infection aim to identify a) causes of CD4+ T cell depletion and b) pathways for immunotherapy and prophylaxis. We find that dendritic cells are not readily infected by HIV- 1 but serve as vehicles for vigorous cytopathic infections, transmitting HIV-1 to CD4+ T cells that are responding to antigens being presented by the APCs. To extend this finding we will test if dendritic cells in other sites [skin, inflammatory exudate] resist infection with HIV-1 but transmit virus to T cells. We will evaluate if the HIV-1 that is associated with dendritic cells is sequestered intracellularly for long periods and in a CD4-dependent fashion. Since there is massive release of virions during the APC-T cell interaction, we will test if antigen-nonspecific memory cells in the environment undergo latent infection that can be activated upon subsequent encounter with specific antigen. This scenario would explain how a small amount of HIV-1 that is carried by dendritic cells to T cells in one immune response may sensitize large numbers of memory T cells for an ultimate cytopathic infection. Since recently infected individuals may use HIV-1 specific T cells to clear the initial viremia, we will perform a clinical study in which we look for cells that block transmission of HIV-1 from dendritic cells to T cells and that kill infected monocytes. Analogous aims embrace our studies of TB. Mycobacteria persist in monocytes, whereas dendritic cells may be important for generating protective T cells. With methods developed in this subproject, we will use dendritic cells to efficiently adsorb and expand mycobacterial reactive T cell clones from the blood of patients that are recovering from TB. The clones will be selected for reactivity with monocytes that harbor replicating M.tub. We will test if the clones can reduce bacillary burden within the monocytes either by a cytolytic or noncytolytic mechanism. Mycobacterial proteins being presented to such clones will be identified. We will test if there is transfer of epitopes from infected monocytes to poorly phagocytic dendritic cells. Our hypothesis is that optimal immunity requires epitopes that are presented by dendritic cells to those T cells that resist mycobacteria within infected monocytes.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Haslett, P; Hempstead, M; Seidman, C et al. (1997) The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. AIDS Res Hum Retroviruses 13:1047-54
Moreira, A L; Corral, L G; Ye, W et al. (1997) Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro. AIDS Res Hum Retroviruses 13:857-63
Klausner, J D; Makonkawkeyoon, S; Akarasewi, P et al. (1996) The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol 11:247-57
Bender, A; Sapp, M; Schuler, G et al. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-35
Berman, M E; Xie, Y; Muller, W A (1996) Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol 156:1515-24
Frankel, S S; Wenig, B M; Burke, A P et al. (1996) Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115-7
Granelli-Piperno, A; Moser, B; Pope, M et al. (1996) Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med 184:2433-8
Johnson, B J; Ress, S R; Willcox, P et al. (1995) Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy. Cytokines Mol Ther 1:185-96
Tramontana, J M; Utaipat, U; Molloy, A et al. (1995) Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1:384-97
Pope, M; Betjes, M G; Hirmand, H et al. (1995) Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J Invest Dermatol 104:11-7

Showing the most recent 10 out of 88 publications